← Eichor
Condition: Fibrodysplasia Ossificans Progressiva Fop Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fibrodysplasia Ossificans Progressiva Fop

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiv
Phase 2 · 24 location(s) · Incyte Corporation · NCT05090891The Fibrodysplasia Ossificans Progressiva (FOP) Registry
Phase N/A · 1 location(s) · The International FOP Association · NCT02745158A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibr
Phase N/A · 5 location(s) · Ipsen · NCT06089616IL1 Inhibition in FOP
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06724562
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.